GGN (Melatonin)
Shop GGN (Melatonin) on KimeraChems · code GUIDE (10% off)Definition
GGN (Melatonin) is a multi-component amino acid and neuroactive cofactor formulation developed for laboratory and analytical research applications. The formulation combines GABAergic and calming-pathway components with an ultra-low-dose melatonin component, making it relevant in research designs exploring sleep initiation, stress-response signaling, neural excitability, and autonomic downshift models. The solution is prepared in sterile water with benzyl alcohol as a preservative. GGN (Melatonin) is not approved for human or veterinary use and is supplied strictly for laboratory and analytical research purposes.
Available Formats
- GABA: 100 mg
- L-Histidine: 100 mg
- L-Theanine: 50 mg
- Taurine: 100 mg
- Melatonin: 200 mcg
Mechanism of Action
GGN (Melatonin) is evaluated as a combined formulation rather than a single active compound. Each component contributes to research-relevant biochemical pathways: The combined formulation is explored in research involving sleep-initiation signaling, neural-excitability regulation, neurotransmitter balance, and circadian-aligned recovery.
- GABA: Studied as an inhibitory neurotransmitter input in neural-excitability and calming-related research models
- L-Theanine: Investigated for its relationship to alpha-wave-associated signaling, excitatory-inhibitory balance, and stress-response pathways
- Taurine: Studied in inhibitory-tone, osmoregulation, and neuromodulatory-stability models, including pathways related to glycine- and GABAergic-signaling dynamics
- L-Histidine: Investigated as a histamine precursor and amino acid variable in arousal, wakefulness, and neurotransmitter-balance research
- Melatonin: Studied as a circadian-signaling hormone influencing sleep timing, circadian-phase markers, and nighttime autonomic-downshift paradigms
Areas of Investigation
GGN (Melatonin) is commonly studied in
- Sleep-onset and sleep-latency paradigms
- Circadian-rhythm and phase-timing models in which melatonin signaling is a key variable
- Neural-excitability and inhibitory-tone research
- Stress-response and autonomic-downshift studies
- Multi-component calming-blend research requiring comparator groups for pathway attribution
Safety Profile
Reported observations are component- and model-dependent and may include
- Next-day grogginess-like effects in models sensitive to melatonin timing or higher cumulative inhibitory signaling
- Headache or nausea in some study contexts
- Vivid-dream-related observations in sleep paradigms involving melatonin
- Confounded wakefulness-related outcomes when histidine or other arousal-associated variables are manipulated within the same protocol
- Overlapping inhibitory effects when combined with other GABAergic agents or sedative comparators, complicating mechanistic attribution
Interaction Notes
GGN (Melatonin) is often explored alongside interventions that overlap with its primary mechanistic pathways.
For educational purposes only. Not for human consumption.